ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

25 hedge funds and large institutions have $1.84M invested in Oramed Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
–
Holders Change %
0%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
4
Closed
5
Calls
$1.55M
Puts
$98K
Net Calls
+$1.45M
Net Calls Change
+$1.33M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$321K
2
Millennium Management
2
Millennium Management
New York
$140K
3
AIM
3
Acrospire Investment Management
Illinois
$71K
4
FANJ
4
Financial Architects (New Jersey)
New Jersey
$29K
5
Simplex Trading
5
Simplex Trading
Illinois
$34K

Top Sellers

1
HSBC Holdings
1
HSBC Holdings
United Kingdom
$0
2
CG
2
Cutler Group
California
$90K
3
GIM
3
Greylin Investment Management
Virginia
$0
4
Group One Trading
4
Group One Trading
Illinois
$0
5
Wells Fargo
5
Wells Fargo
California
$71K
Name Holding Trade Value Shares
Change 		Shares
Change %
GIM
26
Greylin Investment Management
Virginia
– -$69K -10,300 Closed
Group One Trading
27
Group One Trading
Illinois
– -$67K -10,030 Closed
DLHL
28
Donald L. Hagan LLC
Florida
– -$7K -1,000 Closed
WA
29
WealthTrust-Arizona
Arizona
– -$3K -500 Closed
1
2